STERIS (STE) Financials

$251.73 +4.23 (+1.71%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$251.92 +0.18 (+0.07%)

As of 08/22/2025 04:16 PM Eastern

Annual Income Statements for STERIS

This table shows STERIS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	110	291	304	408	397	244	107	378	615
Consolidated Net Income / (Loss)	111	292	305	408	397	243	106	380	616
Net Income / (Loss) Continuing Operations	111	292	305	408	397	284	556	553	612
Total Pre-Tax Income	185	355	369	499	518	367	680	703	796
Total Operating Income	226	400	411	537	548	478	791	836	867
Total Gross Profit	1,026	1,093	1,175	1,320	1,343	1,883	1,981	2,218	2,403
Total Revenue	2,613	2,620	2,782	3,031	3,108	4,223	4,536	5,139	5,460
Operating Revenue	2,613	2,620	2,782	3,031	3,108	4,223	4,536	5,139	5,460
Total Cost of Revenue	1,587	1,527	1,607	1,711	1,764	2,340	2,556	2,921	3,057
Operating Cost of Revenue	1,587	1,527	1,607	1,711	1,764	2,340	2,556	2,921	3,057
Total Operating Expenses	800	693	764	783	795	1,405	1,190	1,382	1,536
Selling, General & Admin Expense	682	632	670	717	731	1,318	1,091	1,252	1,334
Research & Development Expense	59	61	63	66	66	87	98	104	108
Other Operating Expenses / (Income)	-	-	-	-	-	-	0.00	-	48
Restructuring Charge	0.22	0.10	31	0.67	-2.91	0.05	0.49	26	46
Total Other Income / (Expense), net	-42	-45	-42	-38	-31	-111	-111	-133	-70
Interest Expense	45	51	45	40	37	89	108	144	86
Other Income / (Expense), net	2.96	5.73	3.02	1.99	6.35	-22	-2.88	11	16
Income Tax Expense	74	63	64	91	121	82	124	150	185
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-42	-450	-173	4.52
Net Income / (Loss) Attributable to Noncontrolling Interest	0.67	0.71	1.03	0.20	-0.53	-1.02	-1.22	1.84	1.43
Basic Earnings per Share	$1.29	$3.42	$3.59	$4.81	$4.66	$2.50	$1.07	$3.83	$6.24
Weighted Average Basic Shares Outstanding	-	-	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M	98.37M
Diluted Earnings per Share	$1.28	$3.39	$3.55	$4.76	$4.63	$2.48	$1.07	$3.81	$6.20
Weighted Average Diluted Shares Outstanding	-	-	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M	98.37M
Weighted Average Basic & Diluted Shares Outstanding	-	-	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M	98.37M
Cash Dividends to Common per Share	$1.09	$1.21	$1.33	$1.45	$1.57	$1.69	$1.84	$2.03	$2.23

This table shows STERIS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	124	187	124	115	141	-1.38	145	150	174	146	177
Consolidated Net Income / (Loss)	123	187	124	116	141	-1.00	146	151	173	146	178
Net Income / (Loss) Continuing Operations	123	637	131	121	149	172	140	151	173	147	178
Total Pre-Tax Income	160	718	167	156	190	215	175	195	229	197	232
Total Operating Income	191	748	198	192	226	245	186	220	245	216	246
Total Gross Profit	521	409	529	546	560	449	572	579	610	641	628
Total Revenue	1,216	963	1,183	1,238	1,298	1,116	1,280	1,329	1,371	1,481	1,391
Operating Revenue	1,216	963	1,183	1,238	1,298	1,116	1,280	1,329	1,371	1,481	1,391
Total Cost of Revenue	694	554	654	692	738	668	707	750	760	839	763
Operating Cost of Revenue	694	554	654	692	738	668	707	750	760	839	763
Total Operating Expenses	331	-339	331	355	334	203	387	359	365	425	382
Selling, General & Admin Expense	305	128	307	328	308	152	336	329	335	334	354
Research & Development Expense	26	23	25	26	25	25	26	27	27	28	26
Restructuring Charge	0.04	0.36	0.02	-0.02	0.01	26	26	2.80	2.23	15	1.80
Total Other Income / (Expense), net	-30	-30	-31	-36	-37	-30	-10	-25	-17	-19	-14
Interest Expense	29	31	32	37	39	36	30	20	19	17	16
Other Income / (Expense), net	-1.91	0.32	1.38	1.24	2.08	6.33	20	-5.11	2.55	-1.73	1.80
Income Tax Expense	37	81	36	35	41	43	35	44	55	50	54
Net Income / (Loss) Discontinued Operations	-	-	-6.79	-4.45	-7.66	-	5.60	-0.21	-0.08	-0.79	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.50	-0.26	0.24	1.03	0.20	0.38	0.10	1.14	-0.25	0.40	0.60
Basic Earnings per Share	$1.24	$1.87	$1.25	$1.17	$1.42	($0.01)	$1.47	$1.52	$1.76	$1.49	$1.80
Weighted Average Basic Shares Outstanding	198.57M	197.30M	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M	98.37M	98.49M
Diluted Earnings per Share	$1.24	$1.88	$1.25	$1.16	$1.42	($0.02)	$1.46	$1.51	$1.75	$1.48	$1.79
Weighted Average Diluted Shares Outstanding	198.57M	197.30M	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M	98.37M	98.49M
Weighted Average Basic & Diluted Shares Outstanding	198.57M	197.30M	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M	98.37M	98.49M
Cash Dividends to Common per Share	$0.47	$0.47	$0.47	$0.52	$0.52	$0.52	$0.52	$0.57	$0.57	$0.57	$0.57

This table details how cash moves in and out of STERIS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Net Change in Cash & Equivalents	34	-81	19	99	-99	128	-140	-1.34	-35
Net Cash From Operating Activities	424	458	540	591	690	685	757	973	1,148
Net Cash From Continuing Operating Activities	424	458	540	591	690	685	757	973	1,142
Net Income / (Loss) Continuing Operations	111	292	305	408	397	243	106	380	616
Consolidated Net Income / (Loss)	111	292	305	408	397	243	106	380	616
Depreciation Expense	188	178	226	197	219	553	553	565	476
Amortization Expense	-	-	-	0.00	0.00	67	7.36	4.82	0.00
Non-Cash Adjustments To Reconcile Net Income	151	72	5.12	26	50	78	527	300	59
Changes in Operating Assets and Liabilities, net	-26	-84	3.72	-40	23	-256	-436	-277	-10
Net Cash From Investing Activities	-104	-204	-213	-320	-1,154	-667	-383	-887	389
Net Cash From Continuing Investing Activities	-104	-204	-213	-320	-1,154	-667	-383	-887	389
Purchase of Property, Plant & Equipment	-173	-165	-190	-215	-239	-288	-362	-360	-370
Acquisitions	-66	-46	-13	-110	-909	-550	-43	-546	-54
Purchase of Investments	-6.36	0.00	-4.96	0.00	-4.40	0.00	0.00	-1.50	-11
Sale of Property, Plant & Equipment	4.85	2.09	5.57	4.16	0.57	1.74	15	7.38	9.20
Divestitures	136	8.89	2.48	0.44	0.52	170	6.62	9.46	815
Sale and/or Maturity of Investments	-	-	-	-	-	-	0.00	3.88	0.00
Net Cash From Financing Activities	-267	-356	-295	-163	346	116	-499	-85	-1,572
Net Cash From Continuing Financing Activities	-267	-356	-295	-163	346	116	-499	-85	-1,572
Repayment of Debt	-370	-213	-113	-28	-78	-924	-155	-50	-1,087
Repurchase of Preferred Equity	-	-	-	-	-	-721	-91	0.00	-80
Repurchase of Common Equity	-98	-65	-81	-51	-15	-56	-309	-12	-211
Payment of Dividends	-103	-106	-114	-125	-140	-197	-186	-208	-222
Issuance of Debt	-	29	13	35	577	2,010	242	181	25
Issuance of Common Equity	9.98	0.00	0.00	6.05	2.26	3.67	0.00	2.99	2.53
Effect of Exchange Rate Changes	-19	21	-12	-8.73	20	-6.29	-15	-2.06	0.19

This table details how cash moves in and out of STERIS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Net Change in Cash & Equivalents	1.11	-51	0.26	5.14	-18	11	-7.40	-26	-17	17	108
Net Cash From Operating Activities	206	216	281	146	291	255	304	251	333	261	420
Net Cash From Continuing Operating Activities	203	211	281	146	291	255	304	255	333	250	420
Net Income / (Loss) Continuing Operations	123	187	124	116	141	-1.00	146	151	173	146	178
Consolidated Net Income / (Loss)	123	187	124	116	141	-1.00	146	151	173	146	178
Depreciation Expense	138	142	138	152	141	134	113	115	126	122	119
Non-Cash Adjustments To Reconcile Net Income	4.80	-2.64	14	18	20	249	0.20	35	7.90	16	26
Changes in Operating Assets and Liabilities, net	-61	-116	5.75	-140	-15	-128	45	-47	26	-34	96
Net Cash From Investing Activities	-98	-78	-67	-606	-119	-96	688	-105	-124	-70	-109
Net Cash From Continuing Investing Activities	-98	-78	-67	-606	-119	-96	688	-105	-124	-70	-109
Purchase of Property, Plant & Equipment	-92	-71	-67	-83	-119	-91	-108	-102	-89	-71	-94
Acquisitions	-19	-8.55	0.00	-540	-	-6.50	-14	-3.81	-36	-0.48	-15
Sale of Property, Plant & Equipment	11	2.42	0.01	7.36	0.02	0.01	0.00	-	0.00	9.19	0.10
Divestitures	1.40	-	0.00	9.46	-	-	810	0.35	1.52	3.12	0.00
Net Cash From Financing Activities	-120	-192	-214	470	-198	-144	-999	-181	-214	-178	-213
Net Cash From Continuing Financing Activities	-120	-192	-214	470	-198	-144	-999	-181	-214	-178	-213
Repayment of Debt	-15	142	-14	-14	248	173	-886	-92	282	-386	-156
Repurchase of Common Equity	-84	-155	-8.72	-0.49	-2.23	-0.33	-64	-46	-100	-0.26	-11
Payment of Dividends	-48	-48	-47	-51	-59	-51	-52	-56	-58	-57	-56
Issuance of Debt	117	25	-145	536	-387	-266	-	14	-338	344	9.30
Issuance of Common Equity	-	-	0.00	-	2.88	0.11	2.50	-	-	-	0.00
Effect of Exchange Rate Changes	-	-	-0.64	-4.93	7.50	-	-	9.46	-12	3.61	9.60

This table presents STERIS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Total Assets	5,200	5,073	5,441	6,574	11,424	10,822	11,064	10,147
Total Current Assets	990	1,054	1,224	1,212	1,879	2,011	2,869	2,001
Cash & Equivalents	202	221	320	221	348	208	207	172
Accounts Receivable	528	555	586	609	799	865	1,008	1,044
Inventories, net	206	208	264	315	575	604	675	581
Prepaid Expenses	54	60	54	67	157	176	174	204
Plant, Property, & Equipment, net	1,011	1,032	1,112	1,235	1,553	1,633	1,765	1,957
Total Noncurrent Assets	3,200	2,988	3,105	4,127	7,992	7,178	6,429	6,190
Goodwill	2,434	2,323	2,356	3,026	4,404	3,879	4,071	4,096
Intangible Assets	727	605	565	898	3,329	2,077	2,119	1,854
Other Noncurrent Operating Assets	39	60	183	203	259	244	239	239
Total Liabilities & Shareholders' Equity	5,200	5,073	5,441	6,574	11,424	10,822	11,064	10,147
Total Liabilities	1,983	1,887	2,023	2,683	4,879	4,735	4,748	3,531
Total Current Liabilities	398	465	504	578	922	862	931	1,022
Short-Term Debt	-	0.00	20	0.00	143	60	86	125
Accounts Payable	136	153	149	157	226	264	252	281
Accrued Expenses	168	188	192	221	307	298	320	368
Current Deferred & Payable Income Tax Liabilities	0.38	15	14	28	27	40	14	21
Current Employee Benefit Liabilities	94	109	128	150	184	118	165	193
Other Current Liabilities	-	-	-	23	36	30	31	34
Total Noncurrent Liabilities	1,585	1,422	1,519	2,105	3,957	3,873	3,817	2,509
Long-Term Debt	1,316	1,183	1,151	1,651	2,945	3,019	3,120	1,919
Capital Lease Obligations	-	0.00	114	130	155	140	146	125
Noncurrent Deferred & Payable Income Tax Liabilities	160	151	164	237	781	618	480	404
Other Noncurrent Operating Liabilities	109	88	90	88	76	76	72	62
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3,217	3,186	3,418	3,891	6,545	6,087	6,315	6,616
Total Preferred & Common Equity	3,206	3,178	3,405	3,881	6,532	6,077	6,302	6,603
Total Common Equity	3,206	3,178	3,405	3,881	6,532	6,077	6,302	6,603
Common Stock	2,048	1,999	1,982	2,003	4,743	4,486	4,543	4,420
Retained Earnings	1,146	1,339	1,659	1,939	1,999	1,912	2,088	2,475
Accumulated Other Comprehensive Income / (Loss)	12	-160	-235	-61	-210	-321	-329	-292
Noncontrolling Interest	11	7.99	13	10	12	9.97	13	12

This table presents STERIS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	6/30/2025
Total Assets	10,490	10,800	10,822	10,784	11,281	11,435	11,064	10,109	10,242	10,008	10,405
Total Current Assets	1,888	1,977	2,011	2,031	2,174	2,219	2,869	1,940	1,938	1,898	2,058
Cash & Equivalents	258	259	208	209	214	196	207	198	172	155	280
Accounts Receivable	780	823	865	888	940	964	1,008	893	923	915	947
Inventories, net	645	694	604	769	821	856	675	699	689	650	641
Prepaid Expenses	205	200	176	166	199	204	174	151	153	178	190
Plant, Property, & Equipment, net	1,572	1,671	1,633	1,726	1,744	1,844	1,765	1,834	1,930	1,922	2,055
Total Noncurrent Assets	7,029	7,152	7,178	7,027	7,363	7,372	6,429	6,334	6,375	6,189	6,292
Goodwill	3,705	3,853	3,879	3,887	4,040	4,112	4,071	4,057	4,151	4,044	4,223
Intangible Assets	3,077	3,031	2,077	2,865	3,058	2,987	2,119	2,049	2,004	1,923	1,817
Other Noncurrent Operating Assets	246	268	244	275	265	273	239	228	220	222	252
Total Liabilities & Shareholders' Equity	10,490	10,800	10,822	10,784	11,281	11,435	11,064	10,109	10,242	10,008	10,405
Total Liabilities	4,676	4,751	4,735	4,606	5,091	5,007	4,748	3,738	3,632	3,580	3,435
Total Current Liabilities	873	796	862	887	873	914	931	834	805	891	927
Short-Term Debt	151	60	60	63	71	78	86	80	80	125	0.00
Accounts Payable	233	242	264	261	294	277	252	232	235	238	301
Accrued Expenses	304	303	298	333	307	318	320	287	307	335	371
Current Deferred & Payable Income Tax Liabilities	17	25	40	64	32	25	14	57	5.85	0.00	65
Current Employee Benefit Liabilities	134	131	118	132	136	179	165	149	147	161	155
Other Current Liabilities	34	35	30	34	34	37	31	30	31	32	35
Total Noncurrent Liabilities	3,803	3,955	3,873	3,719	4,218	4,093	3,817	2,904	2,826	2,689	2,509
Long-Term Debt	2,874	3,002	3,019	2,860	3,366	3,231	3,120	2,236	2,156	2,039	1,903
Capital Lease Obligations	143	156	140	165	162	163	146	139	133	124	130
Noncurrent Deferred & Payable Income Tax Liabilities	710	725	618	618	613	621	480	456	463	453	411
Other Noncurrent Operating Liabilities	76	73	76	77	77	78	72	72	74	73	64
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	5,813	6,049	6,087	6,178	6,189	6,428	6,315	6,370	6,610	6,429	6,970
Total Preferred & Common Equity	5,802	6,038	6,077	6,168	6,178	6,415	6,302	6,355	6,593	6,416	6,957
Total Common Equity	5,802	6,038	6,077	6,168	6,178	6,415	6,302	6,355	6,593	6,416	6,957
Common Stock	4,705	4,632	4,486	4,498	4,519	4,534	4,543	4,500	4,491	4,405	4,431
Retained Earnings	1,695	1,771	1,912	1,981	2,046	2,134	2,088	2,178	2,268	2,386	2,597
Accumulated Other Comprehensive Income / (Loss)	-598	-364	-321	-311	-387	-253	-329	-323	-166	-374	-71
Noncontrolling Interest	11	10	9.97	10	11	13	13	16	17	12	13

This table displays calculated financial ratios and metrics derived from STERIS's official financial filings.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.28%	6.19%	8.94%	2.53%	35.91%	7.41%	13.28%	6.24%
EBITDA Growth	0.00%	39.93%	9.59%	15.05%	5.12%	39.03%	24.63%	5.68%	-4.13%
EBIT Growth	0.00%	76.99%	2.08%	30.19%	2.91%	-17.74%	72.74%	7.48%	4.17%
NOPAT Growth	0.00%	142.39%	3.32%	29.39%	-4.25%	-11.88%	74.56%	1.76%	1.13%
Net Income Growth	0.00%	163.60%	4.50%	33.84%	-2.69%	-38.80%	-56.43%	259.20%	62.09%
EPS Growth	0.00%	164.84%	4.72%	34.08%	-2.73%	-46.44%	-56.85%	256.07%	62.73%
Operating Cash Flow Growth	0.00%	7.91%	17.89%	9.46%	16.78%	-0.70%	10.53%	28.58%	17.96%
Free Cash Flow Firm Growth	0.00%	0.00%	113.30%	-63.41%	-432.34%	-458.72%	156.74%	-101.33%	2,922.82%
Invested Capital Growth	0.00%	0.00%	-4.46%	5.90%	24.37%	73.17%	-14.89%	8.53%	-1.23%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	1.84%	1.65%	-0.58%	-5.17%	-4.97%	1.13%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	1.99%	-0.48%	16.75%	72.53%	1.64%	-1.77%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	2.61%	-2.09%	-0.09%	493.45%	3.14%	-1.37%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	3.97%	-8.50%	5.78%	656.23%	-3.12%	-2.35%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	3.75%	-8.43%	-12.50%	463.64%	-33.09%	31.36%
EPS Q/Q Growth	0.00%	0.00%	0.00%	3.70%	-8.13%	-14.19%	635.00%	-33.28%	31.91%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	3.56%	-1.62%	-2.30%	6.18%	4.18%	0.52%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-12.85%	6.91%	239.73%	-46.17%	-57.68%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-1.66%	-0.72%	-2.96%	-10.80%	-10.15%	0.60%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	39.28%	41.71%	42.23%	43.55%	43.22%	44.59%	43.66%	43.17%	44.01%
EBITDA Margin	15.97%	22.29%	23.00%	24.29%	24.91%	25.48%	29.56%	27.58%	24.89%
Operating Margin	8.66%	15.26%	14.77%	17.72%	17.65%	11.31%	17.44%	16.27%	15.87%
EBIT Margin	8.77%	15.48%	14.88%	17.78%	17.85%	10.80%	17.38%	16.49%	16.16%
Profit (Net Income) Margin	4.23%	11.13%	10.95%	13.46%	12.77%	5.75%	2.33%	7.40%	11.28%
Tax Burden Percent	59.92%	82.15%	82.58%	81.78%	76.69%	66.21%	15.55%	54.08%	77.38%
Interest Burden Percent	80.57%	87.52%	89.13%	92.53%	93.30%	80.39%	86.30%	82.96%	90.23%
Effective Tax Rate	40.08%	17.85%	17.42%	18.22%	23.32%	22.45%	18.24%	21.28%	23.19%
Return on Invested Capital (ROIC)	0.00%	15.17%	8.01%	10.31%	8.55%	4.98%	7.40%	7.86%	7.68%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	8.55%	4.66%	7.04%	6.68%	-0.76%	-14.94%	-4.93%	5.43%
Return on Net Nonoperating Assets (RNNOA)	0.00%	2.96%	1.50%	2.04%	2.31%	-0.32%	-5.73%	-1.73%	1.85%
Return on Equity (ROE)	0.00%	18.13%	9.52%	12.35%	10.86%	4.65%	1.68%	6.13%	9.53%
Cash Return on Invested Capital (CROIC)	0.00%	-184.83%	12.57%	4.57%	-13.17%	-48.59%	23.50%	-0.33%	8.92%
Operating Return on Assets (OROA)	0.00%	7.80%	8.06%	10.25%	9.23%	5.07%	7.09%	7.74%	8.32%
Return on Assets (ROA)	0.00%	5.61%	5.93%	7.76%	6.61%	2.70%	0.95%	3.47%	5.81%
Return on Common Equity (ROCE)	0.00%	18.06%	9.49%	12.31%	10.82%	4.64%	1.67%	6.12%	9.51%
Return on Equity Simple (ROE_SIMPLE)	0.00%	9.10%	9.59%	11.98%	10.23%	3.72%	1.74%	6.03%	9.33%
Net Operating Profit after Tax (NOPAT)	136	329	339	439	421	371	647	658	666
NOPAT Margin	5.19%	12.54%	12.20%	14.49%	13.53%	8.77%	14.26%	12.81%	12.19%
Net Nonoperating Expense Percent (NNEP)	0.00%	6.62%	3.35%	3.27%	1.87%	5.73%	22.35%	12.79%	2.25%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	7.58%
Cost of Revenue to Revenue	60.72%	58.29%	57.77%	56.45%	56.78%	55.41%	56.34%	56.83%	55.99%
SG&A Expenses to Revenue	26.10%	24.12%	24.08%	23.65%	23.53%	31.22%	24.04%	24.37%	24.44%
R&D to Revenue	2.27%	2.32%	2.27%	2.16%	2.13%	2.05%	2.17%	2.02%	1.97%
Operating Expenses to Revenue	30.62%	26.45%	27.46%	25.83%	25.57%	33.27%	26.22%	26.89%	28.14%
Earnings before Interest and Taxes (EBIT)	229	406	414	539	555	456	788	847	882
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	417	584	640	736	774	1,076	1,341	1,417	1,359
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	3.37	4.09	3.64	3.10	3.53	3.37
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	23.72	0.00	0.00	155.13	198.05	34.08
Price to Revenue (P/Rev)	0.00	0.00	0.00	3.79	5.10	5.62	4.15	4.32	4.08
Price to Earnings (P/E)	0.00	0.00	0.00	28.15	39.92	97.39	175.79	58.73	36.23
Dividend Yield	1.68%	1.38%	1.08%	1.07%	0.84%	0.71%	0.97%	0.90%	0.98%
Earnings Yield	0.00%	0.00%	0.00%	3.55%	2.51%	1.03%	0.57%	1.70%	2.76%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	2.84	3.20	2.82	2.72	2.91	2.82
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	4.11	5.61	6.31	4.81	4.94	4.45
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	16.92	22.52	24.77	16.28	17.90	17.87
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	23.10	31.43	58.42	27.70	29.95	27.51
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	28.36	41.46	71.94	33.76	38.55	36.47
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	21.09	25.28	38.93	28.85	26.07	21.15
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	63.92	0.00	0.00	10.64	0.00	31.42
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.41	0.37	0.38	0.46	0.50	0.53	0.53	0.33
Long-Term Debt to Equity	0.00	0.41	0.37	0.37	0.46	0.47	0.52	0.52	0.31
Financial Leverage	0.00	0.35	0.32	0.29	0.35	0.43	0.38	0.35	0.34
Leverage Ratio	0.00	1.62	1.60	1.59	1.64	1.72	1.76	1.76	1.64
Compound Leverage Factor	0.00	1.41	1.43	1.47	1.53	1.39	1.52	1.46	1.48
Debt to Total Capital	0.00%	29.03%	27.08%	27.31%	31.39%	33.14%	34.58%	34.67%	24.68%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.42%	0.00%	1.46%	0.64%	0.89%	1.42%
Long-Term Debt to Total Capital	0.00%	29.03%	27.08%	26.89%	31.39%	31.68%	33.94%	33.78%	23.26%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.25%	0.18%	0.27%	0.18%	0.13%	0.11%	0.14%	0.14%
Common Equity to Total Capital	0.00%	70.72%	72.74%	72.41%	68.43%	66.74%	65.31%	65.19%	75.17%
Debt to EBITDA	0.00	2.25	1.85	1.74	2.30	3.01	2.40	2.37	1.60
Net Debt to EBITDA	0.00	1.91	1.50	1.31	2.02	2.69	2.24	2.22	1.47
Long-Term Debt to EBITDA	0.00	2.25	1.85	1.72	2.30	2.88	2.35	2.30	1.50
Debt to NOPAT	0.00	4.01	3.49	2.92	4.23	8.75	4.98	5.09	3.26
Net Debt to NOPAT	0.00	3.39	2.84	2.20	3.71	7.81	4.65	4.78	3.00
Long-Term Debt to NOPAT	0.00	4.01	3.49	2.88	4.23	8.37	4.88	4.96	3.07
Altman Z-Score	0.00	0.00	0.00	4.87	4.83	3.77	3.42	4.00	5.07
Noncontrolling Interest Sharing Ratio	0.00%	0.35%	0.30%	0.32%	0.32%	0.22%	0.18%	0.19%	0.20%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	2.48	2.27	2.43	2.10	2.04	2.33	3.08	1.96
Quick Ratio	0.00	1.83	1.67	1.80	1.44	1.24	1.25	1.31	1.19
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-4,003	532	195	-648	-3,618	2,053	-27	773
Operating Cash Flow to CapEx	252.35%	280.13%	292.97%	280.74%	288.92%	239.59%	217.90%	275.76%	318.12%
Free Cash Flow to Firm to Interest Expense	0.00	-79.07	11.83	4.84	-17.42	-40.43	19.02	-0.19	8.96
Operating Cash Flow to Interest Expense	9.53	9.04	11.99	14.66	18.55	7.65	7.01	6.74	13.31
Operating Cash Flow Less CapEx to Interest Expense	5.75	5.81	7.89	9.44	12.13	4.46	3.79	4.30	9.13
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.50	0.54	0.58	0.52	0.47	0.41	0.47	0.51
Accounts Receivable Turnover	0.00	4.96	5.14	5.31	5.20	6.00	5.45	5.49	5.32
Inventory Turnover	0.00	7.42	7.76	7.25	6.10	5.26	4.33	4.57	4.87
Fixed Asset Turnover	0.00	2.59	2.72	2.83	2.65	3.03	2.85	3.02	2.93
Accounts Payable Turnover	0.00	11.24	11.13	11.32	11.52	12.23	10.43	11.32	11.48
Days Sales Outstanding (DSO)	0.00	73.57	71.06	68.74	70.23	60.86	66.95	66.53	68.60
Days Inventory Outstanding (DIO)	0.00	49.17	47.01	50.33	59.85	69.41	84.23	79.92	74.98
Days Payable Outstanding (DPO)	0.00	32.47	32.79	32.24	31.68	29.84	34.99	32.24	31.79
Cash Conversion Cycle (CCC)	0.00	90.26	85.27	86.83	98.40	100.43	116.19	114.21	111.79
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	4,332	4,139	4,383	5,451	9,440	8,034	8,719	8,612
Invested Capital Turnover	0.00	1.21	0.66	0.71	0.63	0.57	0.52	0.61	0.63
Increase / (Decrease) in Invested Capital	0.00	4,332	-193	244	1,068	3,989	-1,406	686	-107
Enterprise Value (EV)	0.00	0.00	0.00	12,454	17,433	26,659	21,834	25,373	24,278
Market Capitalization	0.00	0.00	0.00	11,476	15,863	23,751	18,814	22,215	22,269
Book Value per Share	$0.00	$0.00	$37.59	$40.15	$45.47	$65.24	$61.21	$63.78	$67.21
Tangible Book Value per Share	$0.00	$0.00	$2.96	$5.70	($0.51)	($11.99)	$1.22	$1.14	$6.65
Total Capital	0.00	4,533	4,369	4,703	5,672	9,788	9,305	9,667	8,784
Total Debt	0.00	1,316	1,183	1,284	1,780	3,243	3,218	3,352	2,168
Total Long-Term Debt	0.00	1,316	1,183	1,265	1,780	3,101	3,158	3,266	2,043
Net Debt	0.00	1,114	963	965	1,560	2,895	3,010	3,145	1,997
Capital Expenditures (CapEx)	168	163	184	210	239	286	347	353	361
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	390	368	421	413	751	1,001	1,817	932
Debt-free Net Working Capital (DFNWC)	0.00	591	589	740	634	1,100	1,210	2,024	1,104
Net Working Capital (NWC)	0.00	591	589	720	634	957	1,150	1,938	979
Net Nonoperating Expense (NNE)	25	37	35	31	24	128	541	278	50
Net Nonoperating Obligations (NNO)	0.00	1,114	953	965	1,560	2,895	1,947	2,404	1,997
Total Depreciation and Amortization (D&A)	188	178	226	197	219	620	553	570	476
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	14.87%	13.22%	13.88%	13.30%	17.79%	22.07%	35.36%	17.07%
Debt-free Net Working Capital to Revenue	0.00%	22.56%	21.15%	24.42%	20.40%	26.04%	26.67%	39.39%	20.21%
Net Working Capital to Revenue	0.00%	22.56%	21.15%	23.77%	20.40%	22.65%	25.34%	37.71%	17.92%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$3.59	$4.81	$4.66	$2.50	$1.07	$3.83	$6.24
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M	98.37M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$3.56	$4.76	$4.63	$2.48	$1.07	$3.81	$6.20
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M	98.37M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M	98.37M
Normalized Net Operating Profit after Tax (NOPAT)	171	329	365	440	418	371	647	679	701
Normalized NOPAT Margin	6.53%	12.54%	13.12%	14.51%	13.46%	8.77%	14.27%	13.21%	12.84%
Pre Tax Income Margin	7.07%	13.55%	13.26%	16.46%	16.65%	8.69%	15.00%	13.68%	14.58%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.15	8.01	9.20	13.38	14.92	5.10	7.30	5.87	10.23
NOPAT to Interest Expense	3.04	6.49	7.54	10.90	11.31	4.14	5.99	4.56	7.72
EBIT Less CapEx to Interest Expense	1.37	4.78	5.11	8.16	8.50	1.90	4.08	3.42	6.05
NOPAT Less CapEx to Interest Expense	-0.73	3.26	3.45	5.68	4.89	0.95	2.77	2.11	3.53
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	93.20%	36.48%	37.44%	30.62%	35.38%	81.05%	175.56%	54.82%	36.08%
Augmented Payout Ratio	181.34%	58.94%	64.18%	43.19%	39.07%	104.02%	467.17%	57.92%	70.38%

This table displays calculated financial ratios and metrics derived from STERIS's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.58%	13.46%	2.33%	3.14%	6.72%	15.87%	8.12%	7.33%	5.61%	4.31%	8.72%
EBITDA Growth	0.72%	147.96%	13.69%	302.27%	12.95%	-56.66%	-5.55%	-4.41%	1.24%	-6.77%	15.36%
EBIT Growth	-8.03%	414.76%	26.34%	162.81%	20.99%	-66.40%	3.27%	11.29%	8.44%	-5.41%	20.53%
NOPAT Growth	-7.81%	509.41%	19.11%	169.22%	20.95%	-70.49%	-4.32%	14.93%	4.73%	-9.23%	27.48%
Net Income Growth	-13.82%	259.18%	11.77%	136.91%	14.29%	-100.54%	17.57%	29.93%	22.95%	14,678.34%	22.34%
EPS Growth	-12.68%	208.20%	13.64%	136.83%	14.52%	-101.06%	16.80%	30.17%	23.24%	7,500.00%	22.60%
Operating Cash Flow Growth	-15.86%	25.66%	21.31%	40.71%	41.67%	18.08%	8.04%	71.62%	14.28%	2.34%	38.29%
Free Cash Flow Firm Growth	121.27%	153.36%	-34.81%	-184.60%	-160.03%	-123.65%	66.78%	233.46%	355.44%	152.69%	-84.08%
Invested Capital Growth	-7.41%	-14.89%	-2.08%	9.76%	7.75%	8.53%	-4.76%	-8.01%	-11.79%	-1.23%	1.12%
Revenue Q/Q Growth	1.29%	-20.78%	22.85%	4.63%	4.81%	-20.03%	14.63%	3.86%	3.13%	8.02%	-6.04%
EBITDA Q/Q Growth	291.61%	172.56%	-62.16%	2.37%	7.00%	6.19%	-17.55%	3.60%	13.32%	-9.89%	9.03%
EBIT Q/Q Growth	161.54%	296.32%	-73.40%	-3.19%	18.55%	15.27%	-18.25%	4.34%	15.51%	-13.48%	15.56%
NOPAT Q/Q Growth	168.42%	352.60%	-76.69%	-4.11%	19.55%	15.34%	-24.41%	15.17%	8.95%	-13.46%	17.37%
Net Income Q/Q Growth	139.12%	51.60%	-33.79%	-6.01%	21.14%	-100.71%	14,625.05%	3.87%	14.63%	-15.70%	21.86%
EPS Q/Q Growth	139.37%	51.61%	-33.51%	-7.20%	22.41%	-101.41%	7,400.00%	3.42%	15.89%	-15.43%	20.95%
Operating Cash Flow Q/Q Growth	98.01%	4.97%	30.27%	-48.03%	99.35%	-12.51%	19.21%	-17.45%	32.75%	-21.65%	61.05%
Free Cash Flow Firm Q/Q Growth	4.42%	138.70%	-83.23%	-302.36%	25.90%	7.31%	218.29%	61.93%	41.82%	-79.86%	-65.58%
Invested Capital Q/Q Growth	3.25%	-10.80%	12.75%	5.70%	1.36%	-10.15%	-1.06%	2.09%	-2.80%	0.60%	1.29%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	42.89%	42.47%	44.70%	44.11%	43.15%	40.19%	44.74%	43.55%	44.53%	43.31%	45.14%
EBITDA Margin	26.88%	92.48%	28.48%	27.87%	28.45%	34.59%	24.88%	24.82%	27.27%	22.75%	26.40%
Operating Margin	15.69%	77.69%	16.71%	15.47%	17.45%	21.97%	14.50%	16.53%	17.90%	14.60%	17.68%
EBIT Margin	15.53%	77.72%	16.83%	15.57%	17.61%	22.54%	16.07%	16.15%	18.08%	14.48%	17.81%
Profit (Net Income) Margin	10.14%	19.41%	10.46%	9.40%	10.86%	-0.09%	11.37%	11.38%	12.64%	9.87%	12.80%
Tax Burden Percent	76.92%	26.04%	74.22%	74.65%	74.34%	-0.47%	83.04%	77.57%	75.75%	74.03%	76.76%
Interest Burden Percent	84.88%	95.91%	83.75%	80.84%	82.96%	85.65%	85.22%	90.83%	92.30%	92.02%	93.58%
Effective Tax Rate	23.08%	11.24%	21.71%	22.49%	21.62%	20.08%	20.15%	22.32%	24.21%	25.57%	23.24%
Return on Invested Capital (ROIC)	6.16%	35.80%	6.52%	6.03%	6.85%	10.77%	6.85%	7.44%	8.02%	6.85%	8.72%
ROIC Less NNEP Spread (ROIC-NNEP)	5.39%	16.09%	5.43%	5.01%	5.67%	1.72%	6.75%	6.74%	7.55%	6.17%	8.18%
Return on Net Nonoperating Assets (RNNOA)	2.58%	6.17%	2.46%	2.63%	2.84%	0.60%	2.76%	2.94%	3.18%	2.10%	2.46%
Return on Equity (ROE)	8.74%	41.97%	8.99%	8.66%	9.68%	11.37%	9.62%	10.38%	11.19%	8.95%	11.17%
Cash Return on Invested Capital (CROIC)	6.45%	23.50%	9.44%	2.93%	4.83%	-0.33%	12.24%	15.68%	19.99%	8.92%	7.03%
Operating Return on Assets (OROA)	6.61%	31.70%	6.99%	6.58%	7.42%	10.58%	8.05%	7.99%	9.10%	7.46%	9.68%
Return on Assets (ROA)	4.31%	7.92%	4.34%	3.97%	4.57%	-0.04%	5.70%	5.63%	6.37%	5.08%	6.95%
Return on Common Equity (ROCE)	8.73%	41.90%	8.97%	8.64%	9.66%	11.35%	9.60%	10.36%	11.17%	8.93%	11.15%
Return on Equity Simple (ROE_SIMPLE)	-0.48%	0.00%	1.93%	8.91%	8.85%	0.00%	6.32%	6.62%	7.31%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	147	664	155	148	177	196	148	171	186	161	189
NOPAT Margin	12.07%	68.96%	13.08%	11.99%	13.68%	17.56%	11.58%	12.84%	13.56%	10.87%	13.57%
Net Nonoperating Expense Percent (NNEP)	0.77%	19.71%	1.09%	1.02%	1.17%	9.06%	0.10%	0.70%	0.47%	0.67%	0.54%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	1.79%	-	-	-	2.13%	1.83%	2.10%
Cost of Revenue to Revenue	57.11%	57.53%	55.30%	55.89%	56.85%	59.81%	55.26%	56.45%	55.47%	56.69%	54.86%
SG&A Expenses to Revenue	25.09%	13.26%	25.90%	26.52%	23.76%	13.63%	26.23%	24.78%	24.48%	22.55%	25.43%
R&D to Revenue	2.10%	2.42%	2.09%	2.12%	1.95%	2.26%	2.00%	2.03%	2.00%	1.87%	1.90%
Operating Expenses to Revenue	27.20%	-35.22%	27.99%	28.64%	25.70%	18.22%	30.24%	27.02%	26.63%	28.71%	27.46%
Earnings before Interest and Taxes (EBIT)	189	749	199	193	229	252	206	215	248	214	248
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	327	891	337	345	369	386	318	330	374	337	367
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.02	3.10	3.56	3.48	3.35	3.53	3.42	3.63	3.16	3.37	3.40
Price to Tangible Book Value (P/TBV)	0.00	155.13	0.00	0.00	0.00	198.05	87.25	54.56	45.20	34.08	25.78
Price to Revenue (P/Rev)	3.82	4.15	4.82	4.67	4.59	4.32	4.15	4.49	3.76	4.08	4.24
Price to Earnings (P/E)	0.00	175.79	184.26	39.04	37.96	58.73	54.27	55.01	43.39	36.23	36.54
Dividend Yield	0.98%	0.97%	0.84%	0.89%	0.91%	0.90%	0.95%	0.88%	1.06%	0.98%	0.95%
Earnings Yield	0.00%	0.57%	0.54%	2.56%	2.63%	1.70%	1.84%	1.82%	2.30%	2.76%	2.74%
Enterprise Value to Invested Capital (EV/IC)	2.36	2.72	2.75	2.60	2.56	2.91	2.78	2.97	2.62	2.82	2.91
Enterprise Value to Revenue (EV/Rev)	4.44	4.81	5.45	5.40	5.30	4.94	4.58	4.91	4.16	4.45	4.56
Enterprise Value to EBITDA (EV/EBITDA)	27.31	16.28	18.00	13.09	12.77	17.90	17.21	18.96	16.22	17.87	18.04
Enterprise Value to EBIT (EV/EBIT)	159.82	27.70	29.98	18.70	18.12	29.95	28.10	29.85	25.07	27.51	27.47
Enterprise Value to NOPAT (EV/NOPAT)	0.00	33.76	37.03	22.21	21.57	38.55	36.80	38.79	32.91	36.47	35.96
Enterprise Value to Operating Cash Flow (EV/OCF)	29.78	28.85	30.85	29.30	26.55	26.07	24.08	23.75	19.64	21.15	20.09
Enterprise Value to Free Cash Flow (EV/FCFF)	35.13	10.64	28.79	92.68	54.87	0.00	22.15	18.14	12.29	31.42	41.66
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.53	0.53	0.50	0.58	0.54	0.53	0.39	0.36	0.36	0.33	0.29
Long-Term Debt to Equity	0.52	0.52	0.49	0.57	0.53	0.52	0.37	0.35	0.34	0.31	0.29
Financial Leverage	0.48	0.38	0.45	0.52	0.50	0.35	0.41	0.44	0.42	0.34	0.30
Leverage Ratio	1.77	1.76	1.74	1.81	1.78	1.76	1.66	1.68	1.67	1.64	1.54
Compound Leverage Factor	1.51	1.69	1.46	1.47	1.48	1.51	1.42	1.53	1.54	1.51	1.44
Debt to Total Capital	34.72%	34.58%	33.33%	36.77%	35.07%	34.67%	27.82%	26.38%	26.24%	24.68%	22.59%
Short-Term Debt to Total Capital	0.65%	0.64%	0.68%	0.72%	0.79%	0.89%	0.91%	0.89%	1.43%	1.42%	0.00%
Long-Term Debt to Total Capital	34.08%	33.94%	32.64%	36.05%	34.28%	33.78%	26.91%	25.49%	24.81%	23.26%	22.59%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.11%	0.11%	0.11%	0.11%	0.13%	0.14%	0.18%	0.19%	0.14%	0.14%	0.14%
Common Equity to Total Capital	65.17%	65.31%	66.56%	63.12%	64.80%	65.19%	72.00%	73.43%	73.61%	75.17%	77.27%
Debt to EBITDA	4.14	2.40	2.24	1.89	1.79	2.37	1.76	1.72	1.65	1.60	1.44
Net Debt to EBITDA	3.81	2.24	2.08	1.78	1.69	2.22	1.62	1.59	1.54	1.47	1.25
Long-Term Debt to EBITDA	4.06	2.35	2.19	1.86	1.75	2.30	1.70	1.66	1.56	1.50	1.44
Debt to NOPAT	-27.67	4.98	4.60	3.22	3.02	5.09	3.77	3.52	3.36	3.26	2.88
Net Debt to NOPAT	-25.44	4.65	4.29	3.02	2.85	4.78	3.46	3.26	3.13	3.00	2.48
Long-Term Debt to NOPAT	-27.15	4.88	4.50	3.15	2.95	4.96	3.64	3.40	3.17	3.07	2.88
Altman Z-Score	3.17	3.41	3.73	3.39	3.45	3.82	4.50	4.98	4.48	4.85	5.22
Noncontrolling Interest Sharing Ratio	0.18%	0.18%	0.17%	0.19%	0.18%	0.19%	0.21%	0.22%	0.20%	0.20%	0.22%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.48	2.33	2.29	2.49	2.43	3.08	2.33	2.41	2.13	1.96	2.22
Quick Ratio	1.36	1.25	1.24	1.32	1.27	1.31	1.31	1.36	1.20	1.19	1.32
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	867	2,070	347	-703	-521	-490	579	938	1,330	268	92
Operating Cash Flow to CapEx	253.87%	312.63%	422.14%	192.39%	244.90%	278.51%	281.03%	246.07%	373.02%	422.70%	449.20%
Free Cash Flow to Firm to Interest Expense	30.37	67.65	10.73	-19.02	-13.37	-13.56	19.06	47.68	69.65	15.65	5.80
Operating Cash Flow to Interest Expense	7.20	7.05	8.69	3.96	7.48	7.06	10.00	12.75	17.43	15.24	26.42
Operating Cash Flow Less CapEx to Interest Expense	4.36	4.80	6.63	1.90	4.42	4.52	6.44	7.57	12.76	11.63	20.53
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.43	0.41	0.42	0.42	0.42	0.47	0.50	0.49	0.50	0.51	0.54
Accounts Receivable Turnover	6.07	5.45	5.53	5.35	5.24	5.49	5.88	5.72	5.75	5.32	6.06
Inventory Turnover	4.10	4.33	3.70	3.54	3.40	4.57	4.05	4.01	4.06	4.87	4.65
Fixed Asset Turnover	3.00	2.85	2.77	2.77	2.66	3.02	2.94	2.90	2.87	2.93	2.87
Accounts Payable Turnover	11.74	10.43	10.50	9.85	10.16	11.32	12.08	11.47	11.86	11.48	11.69
Days Sales Outstanding (DSO)	60.08	66.95	66.05	68.24	69.64	66.53	62.07	63.87	63.53	68.60	60.27
Days Inventory Outstanding (DIO)	89.09	84.23	98.61	103.10	107.22	79.92	90.07	90.91	89.95	74.98	78.55
Days Payable Outstanding (DPO)	31.08	34.99	34.76	37.06	35.92	32.24	30.22	31.83	30.78	31.79	31.23
Cash Conversion Cycle (CCC)	118.09	116.19	129.90	134.29	140.94	114.21	121.92	122.95	122.70	111.79	107.59
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	9,007	8,034	9,058	9,575	9,705	8,719	8,627	8,808	8,561	8,612	8,724
Invested Capital Turnover	0.51	0.52	0.50	0.50	0.50	0.61	0.59	0.58	0.59	0.63	0.64
Increase / (Decrease) in Invested Capital	-721	-1,406	-192	851	698	686	-431	-767	-1,144	-107	97
Enterprise Value (EV)	21,227	21,834	24,876	24,866	24,804	25,373	23,985	26,133	22,435	24,278	25,398
Market Capitalization	18,259	18,814	21,987	21,469	21,515	22,215	21,713	23,919	20,290	22,269	23,631
Book Value per Share	$60.49	$61.21	$62.53	$62.54	$64.93	$63.78	$64.25	$66.86	$65.00	$67.21	$70.72
Tangible Book Value per Share	($8.48)	$1.22	($5.91)	($9.31)	($6.92)	$1.14	$2.52	$4.45	$4.55	$6.65	$9.32
Total Capital	9,266	9,305	9,267	9,788	9,900	9,667	8,825	8,980	8,716	8,784	9,003
Total Debt	3,218	3,218	3,088	3,599	3,472	3,352	2,455	2,369	2,287	2,168	2,034
Total Long-Term Debt	3,158	3,158	3,025	3,528	3,394	3,266	2,375	2,289	2,162	2,043	2,034
Net Debt	2,958	3,010	2,880	3,386	3,277	3,145	2,257	2,197	2,132	1,997	1,754
Capital Expenditures (CapEx)	81	69	67	76	119	91	108	102	89	62	94
Debt-free, Cash-free Net Working Capital (DFCFNWC)	981	1,001	999	1,158	1,188	1,817	988	1,040	977	932	852
Debt-free Net Working Capital (DFNWC)	1,240	1,210	1,208	1,372	1,384	2,024	1,186	1,212	1,132	1,104	1,131
Net Working Capital (NWC)	1,180	1,150	1,144	1,301	1,305	1,938	1,106	1,132	1,007	979	1,131
Net Nonoperating Expense (NNE)	23	477	31	32	37	197	2.61	19	13	15	11
Net Nonoperating Obligations (NNO)	2,958	1,947	2,880	3,386	3,277	2,404	2,257	2,197	2,132	1,997	1,754
Total Depreciation and Amortization (D&A)	138	142	138	152	141	135	113	115	126	122	119
Debt-free, Cash-free Net Working Capital to Revenue	20.50%	22.07%	21.90%	25.17%	25.37%	35.36%	18.87%	19.53%	18.09%	17.07%	15.28%
Debt-free Net Working Capital to Revenue	25.93%	26.67%	26.47%	29.82%	29.55%	39.39%	22.66%	22.77%	20.96%	20.21%	20.30%
Net Working Capital to Revenue	24.67%	25.34%	25.08%	28.27%	27.87%	37.71%	21.13%	21.26%	18.65%	17.92%	20.30%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.24	$1.87	$1.25	$1.17	$1.42	($0.01)	$1.47	$1.52	$1.76	$1.49	$1.80
Adjusted Weighted Average Basic Shares Outstanding	198.57M	197.30M	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M	98.37M	98.49M
Adjusted Diluted Earnings per Share	$1.24	$1.88	$1.25	$1.16	$1.42	($0.02)	$1.46	$1.51	$1.75	$1.48	$1.79
Adjusted Weighted Average Diluted Shares Outstanding	198.57M	197.30M	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M	98.37M	98.49M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	198.57M	197.30M	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M	98.37M	98.49M
Normalized Net Operating Profit after Tax (NOPAT)	147	665	155	148	178	217	169	173	188	172	190
Normalized NOPAT Margin	12.07%	68.99%	13.09%	11.99%	13.68%	19.42%	13.18%	13.00%	13.69%	11.64%	13.67%
Pre Tax Income Margin	13.19%	74.54%	14.09%	12.59%	14.61%	19.30%	13.70%	14.67%	16.69%	13.33%	16.67%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.61	24.47	6.15	5.22	5.87	6.97	6.77	10.91	12.98	12.53	15.58
NOPAT to Interest Expense	5.14	21.71	4.79	4.02	4.56	5.43	4.88	8.68	9.74	9.40	11.88
EBIT Less CapEx to Interest Expense	3.78	22.21	4.10	3.16	2.81	4.43	3.21	5.73	8.31	8.92	9.70
NOPAT Less CapEx to Interest Expense	2.30	19.45	2.73	1.96	1.50	2.89	1.32	3.49	5.06	5.80	6.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-622.55%	175.56%	159.18%	35.17%	36.03%	54.82%	53.10%	49.98%	46.31%	36.08%	35.02%
Augmented Payout Ratio	-1,248.37%	467.17%	405.39%	80.20%	65.26%	57.92%	69.84%	75.90%	91.38%	70.38%	59.33%

Key Financial Trends

STERIS plc (NYSE: STE) has demonstrated solid financial performance over the past four years, highlighted by steady revenue growth, improving profitability, and robust cash flow generation, although the company has also experienced some fluctuations related to restructuring charges and one-time impairments in earlier periods.

Key Highlights from the Last Four Years:

Revenue Growth: Operating revenue rose from approximately $849 million in Q4 2022 to over $1.39 billion in Q1 2026, showing a consistent upward trajectory in top-line sales.
Profitability Improvement: Net income from continuing operations improved from $93.6 million in Q4 2022 to $178 million in Q1 2026, with diluted EPS increasing from $0.61 to $1.79 over the comparable periods.
Strong Cash Flow from Operations: Operating cash flow rose significantly, reaching $420 million in Q1 2026 from $171.7 million in Q4 2022, reflecting improved earnings quality and working capital management.
Effective Debt Management: STERIS has consistently repaid debt totaling $155.5 million in Q1 2026 and reduced long-term debt from over $3 billion in late 2022 to about $1.9 billion in Q1 2026, supporting a healthier balance sheet.
Capital Expenditures and Investment in Growth: Capital spending remains active, with property, plant, and equipment purchases around $66-$108 million per quarter, indicating ongoing investment to support operations. Moderate acquisitions have been made to bolster the business.
Dividend Policy: The company maintained a consistent quarterly dividend, which has increased modestly from $0.43 per share in early 2022 to $0.57 in 2026, signaling shareholder return commitment.
Restructuring Charges: Various quarters, especially in 2024 and 2025, show restructuring charges, sometimes significant (e.g., $18 million in Q4 2025), which may reflect ongoing operational optimization but can impact short-term profitability.
Interest Expense Trends: Interest expenses have fluctuated between $15 million to $38 million per quarter, correlating with debt levels; ongoing management of interest cost is crucial.
One-Time Impairments and Losses in 2023: The company reported large impairment charges and net losses during 2023 (e.g., negative net income of -$315 million in Q2 2023), indicating some operational or market challenges during that period.
Fluctuations in Working Capital: Changes in operating assets and liabilities have caused variability in operating cash flows, demonstrating volatility that investors should monitor.

Balance Sheet Strength: Total assets remained strong above $10 billion over the period, with common equity increasing from about $6 billion in early 2022 to nearly $7 billion in Q1 2026, reflecting solid capitalization. Cash and equivalents have fluctuated but remain at healthy levels, supporting liquidity needs.

Summary: Overall, STERIS demonstrates steady revenue and earnings growth, strong cash flow generation, and disciplined capital allocation, including dividends and debt repayment. The 2023 period marked a temporary setback due to impairments and losses, but the latest quarterly results show recovery and progress. Retail investors might find STERIS's fundamentals attractive for long-term investment, keeping an eye on restructuring costs and market conditions that influence operating margins.

08/23/25 09:24 PMAI Generated. May Contain Errors.

Frequently Asked Questions About STERIS's Financials

When does STERIS's financial year end?

According to the most recent income statement we have on file, STERIS's fiscal year ends in March. Their fiscal year 2025 ended on March 31, 2025.

How has STERIS's net income changed over the last 8 years?

STERIS's net income appears to be on an upward trend, with a most recent value of $616.07 million in 2025, rising from $110.63 million in 2017. The previous period was $380.08 million in 2024. See where experts think STERIS is headed by visiting STERIS's forecast page.

What is STERIS's operating income?

STERIS's total operating income in 2025 was $866.64 million, based on the following breakdown:

Total Gross Profit: $2.40 billion
Total Operating Expenses: $1.54 billion

How has STERIS's revenue changed over the last 8 years?

Over the last 8 years, STERIS's total revenue changed from $2.61 billion in 2017 to $5.46 billion in 2025, a change of 109.0%.

How much debt does STERIS have?

STERIS's total liabilities were at $3.53 billion at the end of 2025, a 25.6% decrease from 2024, and a 78.1% increase since 2018.

How much cash does STERIS have?

In the past 7 years, STERIS's cash and equivalents has ranged from $171.70 million in 2025 to $348.32 million in 2022, and is currently $171.70 million as of their latest financial filing in 2025.

How has STERIS's book value per share changed over the last 8 years?

Over the last 8 years, STERIS's book value per share changed from 0.00 in 2017 to 67.21 in 2025, a change of 6,721.0%.

Related Companies

This page (NYSE:STE) was last updated on 8/23/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STERIS (STE) Financials

Key Financial Trends

Frequently Asked Questions About STERIS's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

STERIS (STE) Financials

Annual Income Statements for STERIS

Quarterly Income Statements for STERIS

Annual Cash Flow Statements for STERIS

Quarterly Cash Flow Statements for STERIS

Annual Balance Sheets for STERIS

Quarterly Balance Sheets for STERIS

Annual Metrics And Ratios for STERIS

Quarterly Metrics And Ratios for STERIS

Key Financial Trends

Frequently Asked Questions About STERIS's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools